Detalles de la búsqueda
1.
Concurrent Radiotherapy and Panitumumab after Lymph Node Dissection and Induction Chemotherapy for Invasive Bladder Cancer.
J Urol;
201(3): 478-485, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30321552
2.
Endo-Urological Techniques for Benign Uretero-Ileal Strictures Have Poor Efficacy and Affect Renal Function.
Urol Int;
100(1): 18-24, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-28817820
3.
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.
Oncologist;
21(6): 708-15, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27053504
4.
Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation?
J Urol;
195(4 Pt 1): 907-12, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26598424
5.
Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy.
J Urol;
196(6): 1627-1633, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27312316
6.
Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder.
Curr Opin Urol;
25(5): 427-35, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26125511
7.
Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease?
Eur Urol Open Sci;
55: 15-22, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37693729
8.
Results of the York Mason Procedure with and without Concomitant Graciloplasty to Treat Iatrogenic Rectourethral Fistulas.
Eur Urol Focus;
6(4): 762-769, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31402242
9.
Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes.
Eur Urol Focus;
6(6): 1226-1232, 2020 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30559065
10.
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.
Clin Cancer Res;
25(16): 5082-5093, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30224344
11.
Prostate sparing cystectomy for bladder cancer: A two-center study.
Eur J Surg Oncol;
44(9): 1446-1452, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29929902
12.
Reproducibility and Prognostic Performance of the 1973 and 2004 World Health Organization Classifications for Grade in Non-muscle-invasive Bladder Cancer: A Multicenter Study in 328 Bladder Tumors.
Clin Genitourin Cancer;
16(5): e985-e992, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29884516
13.
Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer.
Urol Oncol;
36(8): 361.e7-361.e13, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29880460
14.
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
Eur Urol;
72(4): 544-554, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28390739
15.
Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer.
Bladder Cancer;
2(3): 351-360, 2016 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27500202
16.
Perioperative treatment and radical cystectomy for bladder cancer--a population based trend analysis of 10,338 patients in the Netherlands.
Eur J Cancer;
54: 18-26, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26707593
17.
ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy.
Eur Urol;
69(3): 384-8, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25636205
18.
Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
Eur J Cancer;
69: 1-8, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27814469
19.
Lymph node count at radical cystectomy does not influence long-term survival if surgeons adhere to a standardized template.
Urol Oncol;
33(12): 504.e19-24, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26329817
20.
Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014.
Eur Urol;
68(2): e33-4, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25776733